(Q36571890)

English

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis

scientific article published on 18 August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

0 references

1 reference

Europe PubMed Central

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

15 August 2017

0 references

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

P Devroey

1 reference

Europe PubMed Central

15 August 2017

author name string

E M Kolibianakis

1

1 reference

Europe PubMed Central

15 August 2017

J Collins

2

1 reference

Europe PubMed Central

15 August 2017

B C Tarlatzis

3

1 reference

Europe PubMed Central

15 August 2017

K Diedrich

5

1 reference

Europe PubMed Central

15 August 2017

G Griesinger

6

1 reference

Europe PubMed Central

15 August 2017

publication date

18 August 2006

1 reference

Europe PubMed Central

15 August 2017

Human Reproduction Update

1 reference

Europe PubMed Central

15 August 2017

12

1 reference

Europe PubMed Central

15 August 2017

6

1 reference

Europe PubMed Central

15 August 2017

651-671

1 reference

Europe PubMed Central

15 August 2017

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

GnRH antagonist in assisted reproduction: a Cochrane review

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Resolving methodological and clinical issues in the design of efficacy trials in assisted reproductive technologies: a mini-review

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Thyroid disease and other endocrine disorders in pregnancy

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Preventive attitude of physicians to avoid OHSS in IVF patients

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Multiple birth resulting from ovarian stimulation for subfertility treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

What is the most relevant standard of success in assisted reproduction?: The cumulated singleton/twin delivery rates per oocyte pick-up: the CUSIDERA and CUTWIDERA.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

What is the most relevant standard of success in assisted reproduction? Is BESST (birth emphasizing a successful singleton at term) truly the best?

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

GnRH antagonist in IVF poor-responder patients: results of a randomized trial.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

GnRH antagonists in ovarian stimulation for IVF.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

What is the most relevant standard of success in assisted reproduction?: The value of cryopreservation on cumulative pregnancy rates per single oocyte retrieval should not be forgotten.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles--a prospective, randomized study.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDML038

21 January 2018

Identifiers

10.1093/HUMUPD/DML038

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36571890&oldid=2133282199"